DK0980383T3 - Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener - Google Patents

Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener

Info

Publication number
DK0980383T3
DK0980383T3 DK98918801T DK98918801T DK0980383T3 DK 0980383 T3 DK0980383 T3 DK 0980383T3 DK 98918801 T DK98918801 T DK 98918801T DK 98918801 T DK98918801 T DK 98918801T DK 0980383 T3 DK0980383 T3 DK 0980383T3
Authority
DK
Denmark
Prior art keywords
oestr
estrogens
hydroxy
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
DK98918801T
Other languages
Danish (da)
English (en)
Inventor
Michael Z Kagan
Leonard Alexander Mcdonald
Panolil Raveendranath
Syed Muzafar Shah
Joseph Zeldis
Fangming Kong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0980383T3 publication Critical patent/DK0980383T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98918801T 1997-05-02 1998-04-28 Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener DK0980383T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85056897A 1997-05-02 1997-05-02
PCT/US1998/008481 WO1998050413A1 (en) 1997-05-02 1998-04-28 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens

Publications (1)

Publication Number Publication Date
DK0980383T3 true DK0980383T3 (da) 2003-04-14

Family

ID=25308509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918801T DK0980383T3 (da) 1997-05-02 1998-04-28 Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener

Country Status (15)

Country Link
EP (1) EP0980383B1 (xx)
JP (1) JP2001523266A (xx)
KR (1) KR20010012193A (xx)
CN (1) CN1254341A (xx)
AR (1) AR015375A1 (xx)
AT (1) ATE230413T1 (xx)
AU (1) AU730300B2 (xx)
BR (1) BR9809437A (xx)
CA (1) CA2289008A1 (xx)
DE (1) DE69810461T2 (xx)
DK (1) DK0980383T3 (xx)
ES (1) ES2187963T3 (xx)
HK (1) HK1025336A1 (xx)
WO (1) WO1998050413A1 (xx)
ZA (1) ZA983698B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL364675A1 (en) * 2001-03-16 2004-12-13 Wyeth Estrogen replacement therapy

Also Published As

Publication number Publication date
EP0980383A1 (en) 2000-02-23
CA2289008A1 (en) 1998-11-12
EP0980383B1 (en) 2003-01-02
ES2187963T3 (es) 2003-06-16
HK1025336A1 (en) 2000-11-10
KR20010012193A (ko) 2001-02-15
BR9809437A (pt) 2000-06-13
DE69810461T2 (de) 2003-10-02
JP2001523266A (ja) 2001-11-20
ZA983698B (en) 1999-11-01
AR015375A1 (es) 2001-05-02
ATE230413T1 (de) 2003-01-15
AU7165598A (en) 1998-11-27
CN1254341A (zh) 2000-05-24
AU730300B2 (en) 2001-03-01
WO1998050413A1 (en) 1998-11-12
DE69810461D1 (de) 2003-02-06

Similar Documents

Publication Publication Date Title
NL300952I2 (nl) Peramivir en farmaceutisch aanvaardbare zouten daarvan
DK1218374T3 (da) Farmaceutisk aktive sulfonamidderivater
NO20010556L (no) Fremgangsmate for oftalmisk administrering
PT1220856E (pt) Compostos farmaceuticamente activos
ATE284385T1 (de) Sulfonamidderivate
DE69514087D1 (de) Pharmazeutisch aktive substituierte aromatische verbindungen
NO20005084D0 (no) Heterosykliske glysyl <beta>-alanin derivater som vitronektinantagonister
IS5340A (is) Arýloxýarýlsúlfónýlamínó hýdroxamsýru afleiður
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO20012636D0 (no) Kontrollert frigivelsesformulering som omfatter GNRH-II
DK1140034T3 (da) Formulering af divalproex-natrium med kontrolleret frigivelse
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
PT868911E (pt) Formulacoes de rapamicina para administracao oral
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
FI972103A0 (fi) Fluorokinolonin uusi fysikaalisesti stabiili kiinteä muoto
DK0941097T3 (da) Anvendelse af aktivstofblandinger til fremstilling af hypocholesterolæmiske midler
DE69528843D1 (de) Pharmakologisch aktive 2-mercaptobenzimidazolderivate
DK1075471T3 (da) Idolylderivater som serotonerge midler
DK0980383T3 (da) Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener
NO20011402D0 (no) Tricykliske <delta>3-piperidiner som farmasøytiske midler
NO995821L (no) Anvendelse av 4-substituerte tetrahydropyridiner for fremstilling av medisiner som virker på TGF-<beta>1
NO972905D0 (no) Tienoksasinon-derivater anvendelige som antivirusmidler